SNSE – sensei biotherapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

SNSE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/20

01:38 pm

snse

Sensei Biotherapeutics (NASDAQ:SNSE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Sensei Biotherapeutics (NASDAQ:SNSE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

11/14

07:30 am

snse

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

Medium Report

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

Report

10/30

12:05 pm

snse

Sensei Biotherapeutics (NASDAQ:SNSE) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.

Medium Report

Sensei Biotherapeutics (NASDAQ:SNSE) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.

Report

10/30

09:35 am

snse

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value [Yahoo! Finance]

Neutral Report

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value [Yahoo! Finance]

Report

10/30

09:00 am

snse

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value

Medium Report

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value

Report

10/17

08:00 am

snse

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025

High Report

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025

Report

9/23

07:52 am

snse

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025 [Yahoo! Finance]

Low Report

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025 [Yahoo! Finance]

Report

9/23

07:30 am

snse

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025

Low Report

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.